Tolvaptan nhibitor II Inhibition of the prostaglandin EP2

Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus

Formula: C20H18F2N3NaO5

2-Chloro-2′-deoxyadenosine

6-dibromo-4-methoxyphenyl)-4-{2-methylimidazo[1

Ertugliflozin L-pyroglutamic acid (PF-04971729 L-pyroglutamic acid) is a potent

Tolvaptan nhibitor II Inhibition of the prostaglandin EP2Tolvaptan is a selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). Tolvaptan was approved by the U. S. Food and Drug Administration (FDA) on May 19, 2009. Product information CAS Number: 150683 30 0 Molecular Weight: 448. 94 Formula: C26H25ClN2O3 Chemical Name: N [4 (7 chloro 5